Management of Cardiogenic Shock in Intensive Care Unit: A Case Series Analysis

Introduction: Cardiogenic shock (CC) is a critical condition characterized by acute cardiac failure and tissue hypoxia, affecting around a third of intensive care patients. With mortality exceeding 50%, its early diagnosis and prompt management are essential to improve clinical outcomes. This review highlights the characteristics, etiologies, management and challenges associated with cardiogenic shock.

This study included adult patients (age > 18 years) hospitalized in the ICU (Intensive care unit) at CHU Ibn Rochd for cardiogenic shock between October 2023 and April 2024.

Results and Discussion: Cardiogenic shock is mainly caused by myocardial infarction, accounting for 70-80% of cases, and is often associated with other cardiovascular risk factors such as hypertension and diabetes. Data from 48 patients show a high prevalence of complications such as renal failure and hyperlactatemia. Management of this condition relies on a multidisciplinary approach and includes early revascularization and the use of inotropic drugs. Rapid identification of underlying etiologies enables treatment to be adapted and myocardial function to be improved, while preventing secondary complications.

Conclusion: The management of cardiogenic shock is complex, requiring rapid intervention to optimize prognosis. Therapeutic strategies need to be individually tailored, and ongoing evaluation of clinical practices is essential to reduce mortality. Future research into innovative treatments and improved care protocols can help improve outcomes for patients suffering from this dreaded condition.